By Ben Glickman Astria Therapeutics said Thursday it has received fast-track designation from the U.S. Food and Drug Administration for its …
Astria Therapeutics Gets FDA Fast-Track Designation for Hereditary Angioedema Treatment
Share This Story, Choose Your Platform!
About the Author:
